These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1875040)

  • 21. VIT1/FBXO11 knockdown induces morphological alterations and apoptosis in B10BR mouse melanocytes.
    Li Y; Chen F; Lin F; Guan C; Wei X; Wan Y; Xu A
    Int J Mol Med; 2009 May; 23(5):673-8. PubMed ID: 19360327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant ETS-1 signalling impedes the expression of cell adhesion molecules and matrix metalloproteinases in non-segmental vitiligo.
    Srivastava N; Bishnoi A; Mehta S; Rani S; Kumar R; Bhardwaj S; Sendhil Kumaran M; Keshavamurthy V; Gupta S; Parsad D
    Exp Dermatol; 2020 Jun; 29(6):539-547. PubMed ID: 32350934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies.
    Bleehen SS
    Br J Dermatol; 1976 Mar; 94 suppl 12():43-50. PubMed ID: 773413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural studies in stable vitiligo.
    Panuncio AL; Vignale R
    Am J Dermatopathol; 2003 Feb; 25(1):16-20. PubMed ID: 12544094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pigment cell transplantation for treatment of vitiligo: a progress report.
    Löntz W; Olsson MJ; Moellmann G; Lerner AB
    J Am Acad Dermatol; 1994 Apr; 30(4):591-7. PubMed ID: 8157785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful culture of adult human melanocytes obtained from normal and vitiligo donors.
    Medrano EE; Nordlund JJ
    J Invest Dermatol; 1990 Oct; 95(4):441-5. PubMed ID: 1698887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.
    Mosenson JA; Flood K; Klarquist J; Eby JM; Koshoffer A; Boissy RE; Overbeck A; Tung RC; Le Poole IC
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):209-20. PubMed ID: 24354861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quantitative ultrastructural study of the epidermis basal layer in the vitiligo patches and in the marginal hyperchromic and normal skin (author's transl)].
    Gonçalves RP; Bechelli LM; Trad ES; Zanin LC
    Ann Dermatol Venereol; 1978 Apr; 105(4):395-400. PubMed ID: 686613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Culture of melanocytes obtained from normal and vitiligo subjects.
    Im S; Hann SK; Park YK; Kim HI
    Yonsei Med J; 1992 Dec; 33(4):344-50. PubMed ID: 1309014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphology of melanocytes in hair bulbs and eyes of vitiligo mice.
    Boissy RE; Moellmann GE; Lerner AB
    Am J Pathol; 1987 May; 127(2):380-8. PubMed ID: 3578491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact on tyrosinase expression and export from endoplasmic reticulum by inhibition of 26S proteasome].
    Xu W; Lin FQ; Liu JF; Fu LF; Hong WS; Zhou MN; Xu AE; Guan CP
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):123-7. PubMed ID: 23648349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin.
    Ding GZ; Zhao WE; Li X; Gong QL; Lu Y
    Arch Dermatol Res; 2015 Apr; 307(3):281-9. PubMed ID: 25672813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
    van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
    Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Dutrieux RP; Das PK
    J Invest Dermatol; 1993 Jun; 100(6):816-22. PubMed ID: 7684427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathologic features in vitiligo.
    Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular pathology in the minimally depigmented subline of the vitiliginous Smyth chicken.
    Boissy RE; Gecks S; Smyth JR; Nordlund JJ
    Pigment Cell Res; 1988; 1(5):303-14. PubMed ID: 3148918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo.
    Maresca V; Roccella M; Roccella F; Camera E; Del Porto G; Passi S; Grammatico P; Picardo M
    J Invest Dermatol; 1997 Sep; 109(3):310-3. PubMed ID: 9284096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules.
    Hedley SJ; Metcalfe R; Gawkrodger DJ; Weetman AP; Mac Neil S
    Br J Dermatol; 1998 Dec; 139(6):965-73. PubMed ID: 9990357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker.
    Kubanov A; Proshutinskaia D; Volnukhin V; Katunina O; Abramova T
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):5-9. PubMed ID: 27014772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
    Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T
    J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.